Location: Home
  • search
  • go
  • Relate News
  • 3/4/2014Executive Moves
  • 3/3/2014Improved Prescribing and Reimbursement Practices in Ningxia Pay-for-pe...
  • 3/2/2014CDE Review of Class 1 New Drug Applications Nearly Doubled in 2013
  • 3/2/2014NDRC Solicits Local Government Comments on Liberalizing Price Control ...
  • 3/2/2014Shanghai Pudong Seeks to Become CMO Trial Site
  • 3/2/2014Shanghai Anew Pharma Completes Preclinical Study of Oncology Drug Cand...
  • 2/28/2014APAC Epilepsy Therapeutics Market to Surge 4.7% CAGR by 2019
  • 2/27/2014NHFPC Vice Minister MA Xiaowei Meets PhRMA Delegation
  • 2/27/2014CFDA Issues Guidelines for GSP Onsite Inspections
  • 2/27/2014Zhejiang Announces Centralized Hospital Drug Purchase Data for 2013
  • 2/27/2014Guangzhou Pharmaceutical Group to Step Up Acquisitions for Accelerated...
  • 2/27/2014Upcoming Event: Pharma China Annual Forum 2014 on April 25 in Shanghai
  • 2/27/2014CFDA Vice Minister Yin Li meets Director General of Israeli Ministry o...
  • 2/27/2014Shanxi Taxus Pharma to Acquire U.S. Medical Firm for US$5M
  • 2/27/2014Bayer to Acquire 100% of Chinese OTC Drug Player Dihon Pharma
  • 2/27/2014Hays: Life Sciences Jobs Flourishing in China's Emerging Healthcare Ma...
  • 2/27/2014SMEI: Chinese Pharma Saw Steady Growth in 2013 Despite Challenges (Upd...
  • 2/27/2014Chinese Foreign Trade of Medicines and Health Products Maintained Doub...
  • 2/26/2014Executive Moves
  • 2/25/2014Amcham: US Firms in China Still Optimistic About China Despite Challen...
  • 2/24/2014Dilafor, Lee's Pharma Enter Pact over Childbirth-Aiding Drug
  • 2/24/2014Chinese Pharma Saw 17.9% Growth in 2013
  • 2/22/2014China's Healthcare Reform to Center on Public Hospital Reform in the N...
  • 2/21/2014National Children's Medical Center to be Established in Shanghai
  • 2/21/2014GSK May Be Fined at Home First for Corruption Scandal in China
  • 2/21/2014PKU Pharmacologists Invited to Become Leading Journal Editors
  • 2/21/2014MOFCOM Announces Its Simplified Merger-Review Program
  • 2/20/2014Updated - CFDA Solicits Feedbacks to Its 2nd Draft Amendment to the &q...
  • 2/20/2014MNCs Dominate the Chinese Ophthalmology Drug Market
  • 2/19/2014SIPO Clarifies Supplemental Evidence in Pharmaceutical Patent Applicat...
  • Page:496/790 Total number of articles:23693: [First][<<] [494] [495] [496] [497] [498] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group